BCEL Chart
See on advanced chart >
About
Atreca, Inc. was incorporated in the State of Delaware on June 11, 2010. The Company is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types....
Read More
- HighlightA clinical-stage biotechnology company focused on developing novel therapeutics based on interrogation of the active human immune response
- ExchangeNASDAQ
- Listing Date06/20/2019
- Established Date06/11/2010
- Full-time Employees90
- Address835 Industrial Road Suite 400 San Carlos CA 94070
- Tel1-650-5952595
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry